The Infection Risk of Intrathecal Drug Infusion Pumps after Multiple Refill Procedures
- 1 January 2005
- journal article
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 8 (1) , 36-39
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysisJournal of Neurosurgery, 2002
- Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and SurvivalJournal of Clinical Oncology, 2002
- Continuous Intrathecal Baclofen Infusion by a Programmable Pump in 131 Consecutive Patients with Severe Spasticity of Spinal OriginNeuromodulation: Technology at the Neural Interface, 2002
- Intrathecal Baclofen Pump Use for SpasticityAmerican Journal of Physical Medicine & Rehabilitation, 2000
- Safety and Efficacy of Intrathecal Baclofen Infusion by Implantable Pump for the Treatment of Severe Spinal Spasticity: A Spanish Multicenter StudyNeuromodulation: Technology at the Neural Interface, 2000
- Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitisJournal of Neurosurgery, 2000
- Drug Adverse Events and System Complications of Intrathecal Opioid Delivery for Pain: Origins, Detection, Manifestations, and ManagementNeuromodulation: Technology at the Neural Interface, 1999
- Intrathecal Baclofen Therapy for Spinal Origin Spasticity: Spinal Cord Injury, Spinal Cord Disease, and Multiple SclerosisNeuromodulation: Technology at the Neural Interface, 1999
- Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiologyJournal of Neurosurgery, 1996
- Intrathecal baclofen for spasticity of spinal origin: seven years of experienceJournal of Neurosurgery, 1992